Angiodynamics (ANGO) Change in Cash (2010 - 2026)

Angiodynamics has reported Change in Cash for 17 years, with the latest figure at -$3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 58.97% year-over-year to -$3.8 million; the trailing twelve-month figure through Feb 2026 stood at -$7.0 million (up 79.37% YoY), and the FY2025 full-year result was -$20.2 million, down 164.14% from the prior year.
• Change in Cash for Q1 2026 stood at -$3.8 million, down from $2.9 million in the prior quarter.
• The five-year high for Change in Cash was $17.6 million in Q1 2024, with the low at -$21.1 million in Q3 2024.
• Historically, Change in Cash has averaged $207000.0 across 5 years, with a median of $254000.0 in 2023.
• The largest YoY upside for Change in Cash was 6811.42% in 2024 against a maximum downside of 262.36% in 2024.
• Angiodynamics' Change in Cash stood at $5.3 million in 2022, then plunged by 37.46% to $3.3 million in 2023, then sank by 127.67% to -$916000.0 in 2024, then jumped by 413.97% to $2.9 million in 2025, then slumped by 233.1% to -$3.8 million in 2026.
• The last three Change in Cash figures came in at -$3.8 million (Q1 2026), $2.9 million (Q4 2025), and -$17.1 million (Q3 2025), per Business Quant data.